Adage Capital Partners’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Adage Capital Partners’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-790,000	Closed	-$7.96M	–	1074
2022 Q4	$7.96M	Hold	790,000	–	–	0.02%	690
2022 Q3	$7.82M	Hold	790,000	–	–	0.02%	701
2022 Q2	$7.73M	Hold	790,000	–	–	0.02%	739
2022 Q1	$7.73M	Hold	790,000	–	–	0.01%	763
2021 Q4	$7.68M	Hold	790,000	–	–	0.01%	766
2021 Q3	$7.7M	Hold	790,000	–	–	0.02%	768
2021 Q2	$7.62M	Buy	+790,000	New	+$7.72M	0.01%	764

Adage Capital Partners's MSAC Position: Q1 2023 in Review

Adage Capital Partners sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 790,000 shares — an estimated $7.96M sold.

Adage Capital Partners first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $7.96M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Adage Capital Partners reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Adage Capital Partners sold 790,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $7.96M.
Adage Capital Partners first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Adage Capital Partners's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $7.96M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.